Infarma
Infarma is associated with the Honduran country-code domain infarma.hn. No substantive business, product, customer, or operational information is available in the source material, which contains only a placeholder verification page.
- Company typePrivate
- Founded1952
- HeadquartersEl Prado, Honduras
- Headcount—
- GTM typeB2B and B2C
- OfferingServices
What Infarma does
Infarma operates a web domain registered under the Honduran country-code top-level domain (infarma.hn). Beyond the domain registration and the company name, the source material provides no description of products, services, customer segments, or operational activities. The linguistic structure of the name ("Infarma") carries a pharmaceutical/pharmacy prefix, but no first- or third-party source in the input confirms industry focus, product offering, or business model. No comparative naming analysis is sufficient basis for inference, and this is flagged only as a non-evidentiary observation.
The only accessible web content associated with the domain, accessed via http://infarma.hn/, is a security/verification placeholder page displaying the message: "One moment, please... Please wait while your request is being verified..." No substantive corporate content, product information, legal disclaimers, or team disclosures are present. All structured data fields—headcount, revenue, funding history, technology stack, pricing, customers, partnerships, certifications, regulatory actions, management team, mergers and acquisitions, and geographic operating footprint—are either empty or explicitly marked as "not available" or "unable to determine" in the source input. The company history field is annotated as containing only the verification/waiting page with no substantive content.
Operating status, ownership structure, founding date, legal entity name, subsidiaries, parent company, social media presence, and contact details cannot be determined from the provided data. Because no verifiable first-party or third-party sources describe Infarma's business, technology, or commercial activity, any further characterization would be unsourced speculation. The data gap itself is the dominant finding: the investment thesis on Infarma, whether positive or negative, cannot be constructed from the current evidence set, and primary-source discovery (Honduran corporate registry filings, direct outreach, or alternative web archive captures) is required before any analytical conclusion can be drawn.
Infarma firmographics
Firmographics- Name
- Infarma
- Website
- https://infarma.hn
- Company type
- Private
- Founded year
- 1952
- Short description
- Infarma is associated with the Honduran country-code domain infarma.hn. No substantive business, product, customer, or operational information is available in the source material, which contains only a placeholder verification page.
- Ownership category
- akta.pro rank
Infarma industry classification
Industry- akta.pro primary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
Where Infarma is headquartered
LocationHeadquarters
- HQ city
- El Prado
- HQ country
- Honduras
- HQ region
- Latin America
Markets served
Infarma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
Infarma product offering
Product offeringCore offering
No information available about Infarma's core offerings. The company website at http://infarma.hn/ displays only a verification/waiting page reading "One moment, please... Please wait while your request is being verified..." with no substantive product or service content.
Differentiator
Problem solved
Functional benefit
Infarma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Infarma competitors and assessment
Company assessmentBroad incumbents
- Eurofarma: Brazilian multinational pharmaceutical company with operations across Latin America. Included as a broad regional pharma incumbent based on inference from Infarma's name suggesting pharmaceutical industry.
- Laboratorios Bagó: Argentine-headquartered pharmaceutical manufacturer with Latin American distribution across multiple countries, including Central America. Listed as a broad regional pharma incumbent peer based on the inference from Infarma's name suggesting pharmaceutical industry and its .hn domain.
Regional players
- Genfar: Latin American generics-focused pharmaceutical player (Sanofi-affiliated) with strong Andean and Central American presence. Listed as a regional pharma peer inferred from Infarma's name and Honduras base.
Market position
Customer concentration
Infarma social profiles
Digital presenceInfarma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Infarma leadership team
Management profileNumber of profiles
Infarma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Infarma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Infarma
What does Infarma do?
No information available about Infarma's core offerings. The company website at http://infarma.hn/ displays only a verification/waiting page reading "One moment, please... Please wait while your request is being verified..." with no substantive product or service content.
When was Infarma founded?
Infarma was founded in 1952.
Where is Infarma based?
Infarma is headquartered in El Prado, Honduras, in the Latin America region.
Who are Infarma's main competitors?
Broad incumbents on record are Eurofarma and Laboratorios Bagó. Genfar is listed as a regional player.
Does Infarma have an API?
No public API is recorded for Infarma.
What industry is Infarma in?
Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP).